The FDA granted Seres Therapeutics’ SER-287 orphan drug designation. SER-287 treats pediatric ulcerative colitis.
The FDA approved Ferring Pharmaceutical’s Clenpiq, a low-volume colonoscopy prep solution.
Takeda appointed Toshio Fujimoto, MD, to serve as the general manager of the Health Innovation Park in Shonan, Japan.
More articles on gastroenterology:
GI leader to know: Dr. Essam Quraishi of Gastrointestinal & Liver Consultants
Stock market week-in-review for 5 large GI companies — Nov. 27 to Dec. 1
How AI is improving polyp detection
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
